Combine Effects of Brunnstorm Movement Therapy and LLLT in Chronic Stroke Patient

March 4, 2024 updated by: Riphah International University

Combine Effects of Brunnstorm Movement Therapy and LLLT on Upper Limb Functioning and Hand Dexterity in Chronic Stroke Patient

The primary objective of this study is to determine the combined effects of Brunnstorm movement therapy and low level laser therapy on upper limb function in chronic stroke patient.

Study Overview

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan, 54000
        • Govt. Mian Munshi DHQ Teaching hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age range between 40 & 60 years (16)
  • Both males and females.
  • Combined Effects of Brunnstorm movement therapy and LLLT on Upper limb function Hand dexterity in stroke
  • Patient with maximum Grade 1 and 1+ spasticity according to Modified
  • Ashworth scale and minimum muscle strength of 1 in the biceps brachii muscle.
  • Onset of injury : (1 to 2 years)

Exclusion Criteria:

  • Any comorbidity such as malignancy, inflammatory rheumatologic disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, lupus erythematosus, etc.
  • Have a pacemaker or a history of serious cardiac events or of cardiorespiratory dysfunction.
  • Visual impairment
  • Any other musculoskeletal disorders of extremity
  • Severe cognitive impairment or aphasia leading to difficulty in communication, Participants unwilling to comply with the protocol.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Brunnstorm Movement therapy
this group received Brunnstorm Movement therapy for 3 to 5 sessions per week, each lasting approximately 30 to 60 minutes for 6 weeks
this group received Brunnstorm Movement therapy for 3 to 5 sessions per week, each lasting approximately 30 to 60 minutes for 6 weeks
Experimental: Combined Brunnstorm Movement therapy and low level laser therapy
this group received Combined Brunnstorm Movement therapy and low level laser therapy for 3 to 5 sessions per week, each lasting approximately 30 to 60 minutes for 6 weeks
this group received Combined Brunnstorm Movement therapy and low level laser therapy for 3 to 5 sessions per week, each lasting approximately 30 to 60 minutes for 6 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugle meyer Assessment test
Time Frame: 6th week
6th week
Box and block test
Time Frame: 6th week
6th week
Nine peg hole test
Time Frame: 6th week
6th week
to check Muscle tone
Time Frame: 6th week
Modified Ashworth Scale
6th week
to measure grip Strength
Time Frame: 6th week
Hand handled dynamometer
6th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Binash Afzal, PHD*, Riphah International University Lahore Campus

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2023

Primary Completion (Actual)

September 30, 2023

Study Completion (Actual)

October 10, 2023

Study Registration Dates

First Submitted

January 28, 2024

First Submitted That Met QC Criteria

March 4, 2024

First Posted (Estimated)

March 5, 2024

Study Record Updates

Last Update Posted (Estimated)

March 5, 2024

Last Update Submitted That Met QC Criteria

March 4, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Stroke

Clinical Trials on Brunnstorm movement therapy

Subscribe